October 24, 2022
Dyne Therapeutics
![Dyne](https://mpmbioimpact.com/wp-content/uploads/2022/10/Dyne.png)
Dyne Therapeutics is developing a pipeline of RNA-based therapeutics targeting an array of neuromuscular disorders. Its lead program has demonstrated in vivo muscle knock-down.
Dyne Therapeutics is developing a pipeline of RNA-based therapeutics targeting an array of neuromuscular disorders. Its lead program has demonstrated in vivo muscle knock-down.